Could low muscle mass predict nerve pain from chemo?
NCT ID NCT06996548
First seen Jan 08, 2026 · Last updated Jun 02, 2026 · Updated 23 times
Summary
This study looked at 120 women with early-stage breast cancer to see if having low muscle mass (sarcopenia) before treatment raises the risk of nerve damage from the chemotherapy drug paclitaxel. Researchers measured muscle mass on CT scans and checked for nerve symptoms using questionnaires and nerve tests. The goal was to find out if muscle loss can help predict who might get nerve problems from chemo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ankara Etlik City Hospital
Ankara, Yenimahalle, 06170, Turkey (Türkiye)
-
Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Ankara, Yenimahalle, 06200, Turkey (Türkiye)
-
Gazi University
Ankara, Yenimahalle, 06560, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.